Skip to content
AnalystLens

Markel Group Annual Report, Year Ended Dec 31, 2003

Filing Date
Filed March 15, 2004
Period End
December 31, 2003
Security
MKL
In the record · 2016–202610-K1110-Q338-K100

MKL filed 11 annual reports (10-K), 33 quarterly reports (10-Q) and 100 current reports (8-K) between 2016 and 2026.

  1. FY2015 annual report10-K · Feb ’16Feb ’16
  2. Material agreement8-K · Apr ’19Apr ’19
  3. Leadership change8-K · Aug ’21Aug ’21
  4. Leadership change8-K · May ’25May ’25

Summary

Summary of the 10-K filed March 15, 2004. Cited figures are marked; the original filing is the authoritative source.

Markel Corporation filed this Form 10-K for the fiscal year ended December 31, 2003, describing itself as a seller of specialty insurance products and programs in niche markets across three segments: Excess and Surplus Lines, Specialty Admitted, and London.

In 2003 the company reported net income of $123.5 milliona, or $12.52 per diluted share, up from $75.3 million in 2002. Gross premium volume rose to $2.57 billion from $2.22 billion, and earned premiums reached $1.86 billion. The consolidated U.S. GAAP combined ratio improved to 99% from 103%, producing an underwriting profit of $10.0 million compared with an underwriting loss of $52.7 million in 2002.

Book value per share increased 19% to $140.38, and shareholders' equity rose to $1.38 billionb. The results were shaped by reserve strengthening. Prior-year loss reserve increases totaled $128.6 million, including $55.0 million for asbestos and environmental exposures and $91.1 million at the Investors Brokered Excess and Surplus Lines unit.

The Other segment posted an underwriting loss of $96.1 millionc, and the London Insurance Market segment had an underwriting loss of $25.2 million. Net investment income was $182.6 million and net realized gains were $45.0 million. Operating cash flow was $631.5 million.

Balance sheet items to note include total assets of $8.53 billiond, unpaid losses and loss adjustment expenses of $4.93 billion, and senior long-term debt of $521.5 million after the issuance of $250 million of 6.80% senior notes due 2013. Reinsurance recoverables totaled $1.77 billion, with the ten largest reinsurers representing about 60%. The company paid no cash dividend and stated its strategy is to retain earnings.

Key Highlights

  1. Net income of $123.5 million ($12.52 per diluted share) in 2003, versus $75.3 million in 2002.
  2. U.S. GAAP combined ratio improved to 99% from 103%, with a consolidated underwriting profit of $10.0 million compared with an underwriting loss of $52.7 million in 2002.
  3. Gross premium volume grew to $2.57 billion from $2.22 billion; the Excess and Surplus Lines segment wrote $1.5 billion, up 15%.
  4. Prior-year reserve increases of $128.6 million, including $55.0 million for asbestos and environmental exposures and $91.1 million at Investors Brokered Excess and Surplus Lines.
  5. Book value per share rose 19% to $140.38; shareholders' equity reached $1.38 billion.
  6. Operating cash flow of $631.5 million and an investment portfolio of $5.35 billion, with 18% in equity securities.
  7. Issued $250 million of 6.80% senior notes due 2013; the company does not pay a cash dividend.

Frequently Asked Questions

  1. Why did Markel's underwriting results improve in 2003?

    The consolidated combined ratio improved to 99% from 103%, driven mainly by the Excess and Surplus Lines segment (90% combined ratio) and a return to underwriting profitability in Specialty Admitted (90%). The Other segment still posted a $96.1 million underwriting loss, largely from $94.4 million of prior-year reserve increases on discontinued lines.

  2. What are the main reserve risks disclosed?

    Management said asbestos and environmental reserves are subject to significant uncertainty, citing a $55.0 million reserve increase in 2003. The filing also cites a $91.1 million adverse development at Investors Brokered Excess and Surplus Lines, and states that gross and net reserves may prove inadequate. A 5% change in net unpaid losses would produce a $166 million change in pre-tax earnings.

  3. How strong is Markel's capital position and liquidity?

    Shareholders' equity was $1.38 billion, and the debt-to-total-capital ratio was 29% when the 8.71% Junior Subordinated Debentures are treated as equity (36% if treated as debt). Operating cash flow was $631.5 million. The company had $110.0 million outstanding under its $220 million revolving credit facility, and the holding company held $108.6 million of cash and investments.

  4. Does Markel pay dividends?

    No. The filing states that the company's current strategy is to retain earnings, and it has not paid and does not expect to pay a cash dividend on its common stock.